EUVIMEDEUVIMED entdecken
Crossref

Prognostic value of age-adjusted global glomerulosclerosis in IgA nephropathy and focal segmental glomerulosclerosis

Serkan Aktürk, Ramazan Öztürk, Alper Zenger, Saba Kiremitçi, Murat Duranay

Clinical Nephrology · 18.11.2026

DOI: 10.5414/cn112109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nephrology, erschienen am 18.11.2026. Verfasst von Serkan Aktürk und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Global glomerulosclerosis (GS) reflects chronic and irreversible nephron loss; however, its clinical interpretation is limited by age-related increases. We aimed to evaluate the prognostic value of GS using both conventional and age-adjusted approaches in patients with IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). Materials and methods: In this retrospective cohort study, patients with biopsy-proven IgAN and FSGS were analyzed. GS was evaluated using both conventional measures and an age-adjusted approach based on reference values derived from healthy kidney donors. The primary outcome was defined as a ≥ 50% decline in estimated glomerular filtration rate (eGFR) or progression to end-stage kidney disease. Logistic regression and Cox proportional hazards models were used to assess associations with renal outcomes.

Results

A total of 218 patients were included in the final analysis, of whom 73 (33.5%) were classified as having age-adjusted excess GS. During a mean follow-up of 45.8 ± 23.8 months, 46 patients (21.1%) reached the renal endpoint. Renal events occurred significantly more frequently in patients with excess GS compared to those with expected GS (46.6 vs. 8.3%, p < 0.001). This corresponded to a significantly higher risk of renal progression in patients with excess GS (OR = 9.66, 95% CI 4.57 – 20.43, p < 0.001). In multivariable Cox analysis, excess GS remained independently associated with renal outcome (HR 5.21, 95% CI 1.97 – 13.73, p = 0.001), whereas conventional GS measures showed weaker associations. Each 10% increase in GS ratio was associated with a 24% higher risk of progression (OR 1.24, p = 0.005). Kaplan–Meier analysis demonstrated significantly worse renal survival in patients with excess GS.

Conclusion

Age-adjusted GS is a strong and independent predictor of renal outcome in IgAN and FSGS and provides additional prognostic information beyond conventional GS measures.

Background

Global glomerulosclerosis (GS) reflects chronic and irreversible nephron loss; however, its clinical interpretation is limited by age-related increases. We aimed to evaluate the prognostic value of GS using both conventional and age-adjusted approaches in patients with IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). Materials and methods: In this retrospective cohort study, patients with biopsy-proven IgAN and FSGS were analyzed. GS was evaluated using both conventional measures and an age-adjusted approach based on reference values derived from healthy kidney donors. The primary outcome was defined as a ≥ 50% decline in estimated glomerular filtration rate (eGFR) or progression to end-stage kidney disease. Logistic regression and Cox proportional hazards models were used to assess associations with renal outcomes.

Results

A total of 218 patients were included in the final analysis, of whom 73 (33.5%) were classified as having age-adjusted excess GS. During a mean follow-up of 45.8 ± 23.8 months, 46 patients (21.1%) reached the renal endpoint. Renal events occurred significantly more frequently in patients with excess GS compared to those with expected GS (46.6 vs. 8.3%, p < 0.001). This corresponded to a significantly higher risk of renal progression in patients with excess GS (OR = 9.66, 95% CI 4.57 – 20.43, p < 0.001). In multivariable Cox analysis, excess GS remained independently associated with renal outcome (HR 5.21, 95% CI 1.97 – 13.73, p = 0.001), whereas conventional GS measures showed weaker associations. Each 10% increase in GS ratio was associated with a 24% higher risk of progression (OR 1.24, p = 0.005). Kaplan–Meier analysis demonstrated significantly worse renal survival in patients with excess GS.

Conclusion

Age-adjusted GS is a strong and independent predictor of renal outcome in IgAN and FSGS and provides additional prognostic information beyond conventional GS measures. Author Details Authors Serkan Aktürk1Ramazan Öztürk1Alper Zenger1Saba Kiremitçi2Murat Duranay1 Departments 1 Department of Nephrology, Ankara Training and Research Hospital, and2 Department of Pathology, Ankara University, Ankara, Turkey Address Dr. Serkan Aktürk, Department of Nephrology, Ankara Training and Research Hospital, Ankara, TurkeyEmail: [email protected] Log in for Subscribers Enter your username and password here in order to log in on the website: Username: Password: Forgot your password? Citation Serkan Aktürk, Ramazan Öztürk, Alper Zenger, Saba Kiremitçi, and Murat Duranay. Prognostic value of age-adjusted global glomerulosclerosis in IgA nephropathy and focal segmental glomerulosclerosis . ; : 0-11. doi: 10.5414/CN112109.

Zitieren

APA

Aktürk, S., Öztürk, R., Zenger, A., Kiremitçi, S., & Duranay, M. (2026). Prognostic value of age-adjusted global glomerulosclerosis in IgA nephropathy and focal segmental glomerulosclerosis. Clinical Nephrology. https://doi.org/10.5414/cn112109

Vancouver

Aktürk S, Öztürk R, Zenger A, Kiremitçi S, Duranay M. Prognostic value of age-adjusted global glomerulosclerosis in IgA nephropathy and focal segmental glomerulosclerosis. Clinical Nephrology. 2026. doi:10.5414/cn112109

BibTeX
@article{Aktrk2026,
  author = {Aktürk, Serkan and Öztürk, Ramazan and Zenger, Alper and Kiremitçi, Saba and Duranay, Murat},
  title = {Prognostic value of age-adjusted global glomerulosclerosis in IgA nephropathy and focal segmental glomerulosclerosis},
  journal = {Clinical Nephrology},
  year = {2026},
  doi = {10.5414/cn112109}
}
Kostenlos starten →